Drug-Eluting Coronary-Artery Stents | NEJM Skip to main content NEJM Group Follow Us
Facebook Twitter Instagram YouTube LinkedIn Prepare to become a physician, build your …

These Guidelines represent the third time that the ESC and EACTS have brought together
cardiologists and cardiac surgeons in a joint Task Force to review the ever-increasing body …

Background Percutaneous coronary intervention (PCI) with drug-eluting stents is the
standard of care for treatment of native coronary artery stenoses, but optimum treatment …

always refer to the full text version, which is freely available on the ESC and EACTS
websites. The National Societies of the ESC are encouraged to endorse, translate, and …

The task of developing ESC/EACTS Guidelines covers not only the integration of the most
recent research, but also the creation of educational tools and implementation programmes …

As of March 31, 2020 (median follow-up, 13 days; interquartile range, 2–20 days), 11
patients (39.3%) had died, 1 (3.6%) was still hospitalized in an intensive care unit, and 16 …

Background Myocardial injury is frequent among patients hospitalized with coronavirus
disease-2019 (COVID-19) and is associated with a poor prognosis. However, the …

Importance Severe acute respiratory syndrome coronavirus 2 infection has evolved into a
global pandemic. Low-dose colchicine combines anti-inflammatory action with a favorable …

Objective To investigate whether revascularisation improves prognosis compared with
medical treatment among patients with stable coronary artery disease. Design Bayesian …

Aims The efficacy of durable polymer drug-eluting stents (DES) is delivered at the expense
of delayed healing of the stented vessel. Biodegradable polymer DES aim to avoid this …